Losing weight can feel like climbing a mountain with no clear path. The one-size-fits-all advice—like “eat less, move ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

Millions of individuals around the world experience symptoms of erectile dysfunction (ED). But, for how common ED is, it can ...

The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s inauguration fund.

Hims & Hers is the latest company to donate ... spokesperson said in a statement obtained by Axios. In addition to erectile dysfunction treatment, the telehealth company has been a major player ...

Haveri: Haveri Institute of Medical Sciences (HIMS) introduced a groundbreaking mobile application, ‘HIMS Haveri', establishing itself as the pioneer among govt-run medical institutions to ...

The study authors said further research is needed to clarify a causal relationship between IBD and ED. There are no known cures for IBD or IBS. Patients may find relief with medicine, a healthier ...

Furthermore, by getting a generic version of Liraglutide-based drugs, Hims and Hers could potentially enjoy better margins than what they are getting with compounded GLP-1s right now. On that note ...

Weight-loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medications as alternatives to the traditional — and often ineffective — advice ...

Ed Miliband says he ‘can still make a contribution’ 10 years after stepping down as leader of his party (Picture: Metro/Getty/AP/Reuters) The day Ed Miliband ...

Yet Hims & Hers is still up nearly 200% over the past 12 months. The company has made headlines for selling compounded versions of GLP-1 agonists, the popular diabetes and weight loss drugs ...

As Medscape marks its 30th anniversary, we are collaborating with physicians, scientists, and futurists from around the globe to boldly envision the future of medicine in the year 2050.